InvestorsHub Logo

steadykickin

05/01/19 7:38 PM

#535 RE: Etailer #534

What no Arepa? Good stuff with some scrambled eggs.

john1311

05/04/19 6:53 AM

#538 RE: Etailer #534

Khiron Life Sciences Reports 2018 Fiscal Year End Results and Provides Corporate Update

Secured approximately $40 million of investment capital for cultivation site construction, product development and distribution

Became the first Colombian cannabis company to list on the TSX Venture Exchange

Geographic footprint to countries including Colombia, Mexico, Chile, Peru, Uruguay and Italy

Received first INVIMA approvals for seven CBD-based cosmeceutical products in Colombia.

Generated first revenue in Q4 2018 with the commercialization of the Kuida® brand of cosmeceutical products

Increased potential cultivation capacity to 220 tonnes per annum through organic growth and pending acquisitions

Made key management and board appointments including Mr. Vicente Fox as Director of the Board, the former CEO of Coca Cola Mexico and former President of Mexico

Net working capital position of $17,493,835

Raised $28,842,000 in bought deal financing including full exercise of over-allotment option, subsequent to the quarter